MYOSITIS Clinical Trial
Official title:
Kinesio Taping Effects Applied With Different Directions and Tensions on Electromyography, Electroencephalography, Local Temperature and Muscle Strength
Verified date | July 2015 |
Source | Universidade Estadual de Goiás |
Contact | n/a |
Is FDA regulated | No |
Health authority | Brazil: Ethics Committee |
Study type | Interventional |
The Kinesio Taping (KT ) method was developed more than thirty years ago in order to cause sensory effects through the epidermis and dermis, generating a variety of physiological effects in other systems. Clinical effects are well known levels in muscle, neurological system, injuries, inflammation, edema, among other physiological effects are thus largely in the theoretical framework. Objectives: The aim of this study is to evaluate the Electromyographic (EMG), Electroencephalographic (EEG), muscle temperature and flexibility effects with the Rectus Femoral muscle KT application. Methods: This is a pilot study with six subjects in which they were divided into two groups, A and B. Group A received the application of KT from muscle Origin to Insertion and group B Insertion to Origin, with both groups taped the non-dominant limb and the dominant limb was used as control group. The first application was conducted at 0% and the second with 75 to 100% tension. Evaluations were performed before the first application, immediately and 24 hours later. After this last evaluation, was withdrawn taping, evaluated without taping, reapplied 75 to 100 % of rated voltage and in sequence. The sixth last review was conducted 24 hours after this last application. Before every application a specific vibration was performed on the patellar tendon in order to trigger a neurophysiological imbalance rectus femoral.
Status | Completed |
Enrollment | 30 |
Est. completion date | January 2015 |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Individuals who have authorized the evaluation procedure and through the Term Informed Consent; - Individuals male and female of any race, duly enrolled in some college course of Universidade Salgado de Oliveira aged between 18-50 years old; - Healthy subjects without disorders of locomotion without injury history the last 6 months in the lower limbs. Exclusion Criteria: - They are considered unfit for research individuals who do not meet the requirements listed above ; - Individuals who have higher body mass index (BMI ) to 24.99, as the concentrated presence of fat on muscles can limit the effect of bracing; - Individuals with musculoskeletal disorders and referring pain. Since there report that the pain and dysfunction of movement restricted range of motion and function muscular18 ; - Individuals who possess too much on the thigh in which prevent proper attachment of bracing and the EMG electrode , or who refuse to perform the trichotomy . - they show taping allergy ( an allergy test by putting a small bandage on the skin will be held and observed for 24 hours ) ; - Patients with any contraindication how physical activity according to the guideline of the American College of Sports Medicine (ACSM , 1995), nerve root involvement, cardiorespiratory conditions and pregnancy . |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Universidade Estadual de Goiás | University of Brasilia |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Muscle Stregth | Group A (n= 15) received the application of KT from muscle (Rectus femoral) Origin to Insertion, Group B (n= 15) from insertion to origin at the non dominant limb, and the dominant limb will be used as control group. The strength will be measure by a Hand Hold Dynamometer (Kg/F) during an maximum isometric voluntary contraction. | The outcome will be evaluated 24 hours after the intervention | Yes |
Other | Local Temperture | Group A (n= 15) received the application of KT from muscle (Rectus femoral) Origin to Insertion, Group B (n= 15) from insertion to origin at the non dominant limb, and the dominant limb will be used as control group. The temperature will be measure using Thermography (Degrees Celsius) before the KT applications, and 24 hs after staying with the KT applied to the skin. | The outcome will be evaluated 24 hours after the intervention | Yes |
Primary | Muscle Activity | Group A (n= 15) received the application of KT from muscle (Rectus femoral) Origin to Insertion, Group B (n= 15) from insertion to origin at the non dominant limb, and the dominant limb will be used as control group. The Eletromiography/ EMG (mV) will be measure during an maximum isometric voluntary contraction. | The outcome will be evaluated 24 hours after the intervention | Yes |
Secondary | Neurologic Activity | Group A (n= 15) received the application of KT from muscle (Rectus femoral) Origin to Insertion, Group B (n= 15) from insertion to origin at the non dominant limb, and the dominant limb will be used as control group. The Eletroencephalography - EEG (Hz) will be measure during an maximum isometric voluntary contraction. Will be analyzed 8 channels related with the motor activity located between the frontal and the central lobe. | The outcome will be evaluated 24 hours after the intervention | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06284954 -
A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis
|
Phase 2 | |
Completed |
NCT06300983 -
Effectiveness of a Psychoeducational Intervention on Myositis Patients' Quality of Life and Well-Being
|
N/A | |
Recruiting |
NCT05832034 -
Add-on Intravenous Immunoglobulins in Early Myositis
|
Phase 2 | |
Recruiting |
NCT05979441 -
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
|
Phase 3 | |
Active, not recruiting |
NCT02468895 -
MYOPROSP - a Prospective Cohort Study in Myositis
|
||
Recruiting |
NCT01501019 -
Exercise in Sjogren, Myositis and Takayasu's Arteritis
|
N/A | |
Recruiting |
NCT05523167 -
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.
|
Phase 2/Phase 3 | |
Completed |
NCT03414086 -
Predictor of Clinical Response to Acthar in Myositis
|
||
Not yet recruiting |
NCT01702870 -
Diagnostic Accuracy of MR in Myositis
|
N/A | |
Terminated |
NCT03937856 -
Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases
|
N/A | |
Completed |
NCT03440034 -
Study of Pioglitazone in Sporadic Inclusion Body Myositis
|
Phase 1 | |
Recruiting |
NCT05895786 -
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
|
Phase 3 | |
Completed |
NCT00001331 -
Genetic and Family Studies of Inherited Muscle Diseases
|
N/A | |
Terminated |
NCT04309227 -
Comparison of Training Load With/Out Blood Flow Restriction Training in Rheumatoid Populations
|
N/A | |
Completed |
NCT03059394 -
Validation of Rehab Assessments in Myositis Patients
|
N/A | |
Completed |
NCT00106184 -
Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
|
Phase 2 | |
Recruiting |
NCT04367350 -
Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement
|
||
Completed |
NCT01734369 -
Environmental Risk Factors for Myositis in Military Personnel
|
||
Recruiting |
NCT02450396 -
Pregnancy and Medically Assisted Conception in Rare Diseases
|
||
Recruiting |
NCT03912428 -
Novel PET Radioligands as Inflammatory Biomarkers in Rheumatoid Arthritis and Myositis
|
Phase 1 |